5 September 2024 - We are expanding on our existing mandate and functions — which span drugs, medical devices, and clinical interventions — and including developing new programs focused on appropriate use, data and analytics, and system coordination and alignment.

As part of our strategic planning process, we hosted a series of virtual town halls and distributed a public survey to gather input from our key partners, including patients, clinicians and clinical groups, industry, academic and research communities, and the broader community. These engagements were intended to gather input about Canada’s Drug Agency today, as well as perspectives on our future direction.

Read Canada's Drug Agency News